Vitamins And Dietary Supplements in the US
Euromonitor International's Vitamins And Dietary Supplements in the US market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 52 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Child-specific vitamins and dietary supplements; Dietary supplements; Tonics and bottled nutritive drinks; Vitamins
Table of contents
VITAMINS AND DIETARY SUPPLEMENTS IN THE US : MARKET INSIGHT
HEADLINES
TRENDS - VITAMINS
TRENDS – DIETARY SUPPLEMENTS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2008
SECTOR DATA
Table 1 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 2 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 3 Dietary Supplements by Positioning 2006-2008
Table 4 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 5 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 6 Vitamins Brand Shares by Value 2005-2008
Table 7 Dietary Supplements Brand Shares by Value 2005-2008
Table 8 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - USA
ADAMS RESPIRATORY THERAPEUTICS INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Adams Respiratory Therapeutics Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Adams Respiratory Therapeutics Inc: Competitive Position 2008
BAYER CORP - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Bayer Corp: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 5 Bayer Corp: Competitive Position 2008
CHATTEM INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Chattem Inc: Key Facts
Summary 7 Chattem Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Chattem Inc: Competitive Position 2008
GENERAL NUTRITION CENTERS INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 9 General Nutrition Centers Inc: Key Facts
Summary 10 General Nutrition Centers Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 General Nutrition Centers Inc: Competitive Position 2008
GLAXOSMITHKLINE CONSUMER HEALTH - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 12 GlaxoSmithKline: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 GlaxoSmithKline: Competitive Position 2008
JOHNSON & JOHNSON INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Johnson & Johnson Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2008
Summary 16 Pfizer Consumer Healthcare Ltd: Competitive Position 2008
Summary 17 Johnson & Johnson Consumer Products Inc: Competitive Position 2008
Summary 18 Advanced Care Products: Competitive Position 2008
Summary 19 Neutrogena: Competitive Position 2008
MANNATECH INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 20 Mannatech Inc: Key Facts
Summary 21 Mannatech Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 22 Mannatech Inc: Competitive Position 2008
MELALEUCA INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Melaleuca Inc: Key Facts
Summary 24 Melaleuca Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 25 Melaleuca Inc: Competitive Position 2008
PROCTER & GAMBLE CO, THE - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Procter & Gamble: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 27 Procter & Gamble: Competitive Position 2008
WYETH CONSUMER HEALTHCARE INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 28 Wyeth Consumer Healthcare: Key Facts
Summary 29 Wyeth Consumer Healthcare: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 30 Wyeth Consumer Healthcare: Competitive Position 2008
OTC HEALTHCARE IN THE US
EXECUTIVE SUMMARY
OTC industry proves recession resistant
Fusion of standard and herbal medicine emerges
Private label gains share
Retailers focus on consumer health
Industry growth is expected to remain dynamic
KEY TRENDS AND DEVELOPMENTS
America is becoming less healthy
Fusion of standard and natural medicine
Behind-the-counter category emerges
US economic slowdown promotes self-medication
Private label proves to be a tenacious competitor
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 31 OTC Healthcare Switches 2005-2007
MARKET INDICATORS
Table 10 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 11 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 12 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 13 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 14 OTC Healthcare Company Shares by Value 2004-2008
Table 15 OTC Healthcare Brand Shares by Value 2005-2008
Table 16 Penetration of Private Label by Sector 2003-2008
Table 17 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 18 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 19 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 20 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
DEFINITIONS
Summary 32 Research Sources